Who owns Lexaria Bioscience Corp., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
No 13D/13G disclosures on record for Lexaria Bioscience Corp..
No holder has disclosed crossing the 5% threshold in filings since December 18, 2024, when our coverage begins.
Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Lexaria Bioscience Corp. they hold. Together these 701 managers report 73.53% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. | $1.76B | 2,236,557 | 0.03% | 9.02% | June 30, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $621M | 778,042 | 0.03% | 3.14% | June 30, 2026 |
699 more institutional holders behind a free account
See every manager reporting Lexaria Bioscience Corp., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 413 funds hold 30.43% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | $671M | 0.60% | 3.39% | June 30, 2026 |
| First Trust RBA American Industrial Renaissance ETF | $544M | 4.73% | 2.75% | June 30, 2026 |
411 more funds behind a free account
See every fund holding Lexaria Bioscience Corp. and what share of its net assets the position represents.
Sign up freeLoading...
